Malignant Reproductive System Neoplasm — Trials

Malignant Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,804
Recruiting: 1,546
Ph III recruiting: 175
Growth YoY: +16.2%
Industry share: 21%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,473)

clinicaltrialsPublishedShowing 501–550 of 1,728 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03373006	A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer	completed	Phase 2	20	HALO DiagnosticsINDUSTRY	1	May 25, 2022	clinicaltrials
NCT00432094	Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors	completed	Phase 2	23	Masonic Cancer Center, University of MinnesotaOTHER	1	May 17, 2022	clinicaltrials